Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Non-Current Deferred Tax Liability of $106.5 million in Q1 2026, down 1.59% quarter-over-quarter from $108.3 million in Q4 2025, and up 28.21% on a YoY basis from $83.1 million in Q1 2025.
Koninklijke Philips (PHG) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Koninklijke Philips' Non-Current Deferred Tax Liability history runs 18 years deep, the most recent figure standing at $106.5 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 28.21% year-over-year to $106.5 million; the TTM figure through Mar 2026 stood at $106.5 million (up 28.21% YoY), while the FY2025 annual figure was $108.3 million, up 25.07% from the prior year.
- Non-Current Deferred Tax Liability was $106.5 million for Q1 2026 at Koninklijke Philips, down from $108.3 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $116.3 million in Q2 2022 to a low of $73.0 million in Q2 2023.
- Historically, Non-Current Deferred Tax Liability has averaged $90.7 million across 5 years, with a median of $86.6 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability jumped 69.44% in 2022, then slumped 37.27% in 2023.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $92.8 million in 2022, then decreased by 17.72% to $76.4 million in 2023, then advanced by 13.31% to $86.6 million in 2024, then gained by 25.07% to $108.3 million in 2025, then fell by 1.59% to $106.5 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $106.5 million (Q1 2026), $108.3 million (Q4 2025), and $90.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.27 Bn | 16.86 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106.54 Mn |
| Mar 31, 2026 | 106.54 Mn |
| Dec 31, 2025 | 108.26 Mn |
| Dec 31, 2025 | 108.26 Mn |
| Sep 30, 2025 | 90.02 Mn |
| Sep 30, 2025 | 90.02 Mn |
| Jun 30, 2025 | 86.03 Mn |
| Jun 30, 2025 | 86.03 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Mar 31, 2025 | 83.10 Mn |
| Dec 31, 2024 | 86.56 Mn |
| Dec 31, 2024 | 86.56 Mn |
| Jun 30, 2024 | 78.61 Mn |
| Jun 30, 2024 | 78.61 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Jun 30, 2023 | 72.96 Mn |
| Jun 30, 2023 | 72.96 Mn |
| Dec 31, 2022 | 92.84 Mn |
| Dec 31, 2022 | 92.84 Mn |